nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR7—coronary artery disease	0.384	0.665	CbGaD
Amisulpride—HTR2A—coronary artery disease	0.193	0.335	CbGaD
Amisulpride—HTR2B—cardial valve—coronary artery disease	0.0191	0.218	CbGeAlD
Amisulpride—HTR7—pulmonary artery—coronary artery disease	0.00661	0.0755	CbGeAlD
Amisulpride—HTR7—sympathetic nervous system—coronary artery disease	0.00643	0.0734	CbGeAlD
Amisulpride—HTR2A—arteriole—coronary artery disease	0.0063	0.0719	CbGeAlD
Amisulpride—HTR7—vagus nerve—coronary artery disease	0.00623	0.0711	CbGeAlD
Amisulpride—HTR7—vein—coronary artery disease	0.00602	0.0687	CbGeAlD
Amisulpride—HTR7—autonomic nervous system—coronary artery disease	0.00432	0.0494	CbGeAlD
Amisulpride—HTR2A—pulmonary artery—coronary artery disease	0.00413	0.0471	CbGeAlD
Amisulpride—HTR2A—sympathetic nervous system—coronary artery disease	0.00401	0.0458	CbGeAlD
Amisulpride—HTR2A—vagus nerve—coronary artery disease	0.00389	0.0443	CbGeAlD
Amisulpride—HTR2A—vein—coronary artery disease	0.00375	0.0429	CbGeAlD
Amisulpride—HTR2A—autonomic nervous system—coronary artery disease	0.0027	0.0308	CbGeAlD
Amisulpride—HTR7—artery—coronary artery disease	0.00245	0.028	CbGeAlD
Amisulpride—Metoclopramide—CYP11B2—coronary artery disease	0.00237	0.769	CrCbGaD
Amisulpride—HTR7—endothelium—coronary artery disease	0.00207	0.0236	CbGeAlD
Amisulpride—HTR2A—artery—coronary artery disease	0.00153	0.0175	CbGeAlD
Amisulpride—HTR2A—endothelium—coronary artery disease	0.00129	0.0147	CbGeAlD
Amisulpride—HTR2B—heart—coronary artery disease	0.00105	0.012	CbGeAlD
Amisulpride—HTR2B—cardiovascular system—coronary artery disease	0.000995	0.0114	CbGeAlD
Amisulpride—HTR7—heart—coronary artery disease	0.000903	0.0103	CbGeAlD
Amisulpride—HTR7—cardiovascular system—coronary artery disease	0.000852	0.00973	CbGeAlD
Amisulpride—HTR2B—blood—coronary artery disease	0.000787	0.00898	CbGeAlD
Amisulpride—Remoxipride—HTR2A—coronary artery disease	0.000714	0.231	CrCbGaD
Amisulpride—HTR7—blood—coronary artery disease	0.000674	0.00769	CbGeAlD
Amisulpride—HTR2A—heart—coronary artery disease	0.000563	0.00643	CbGeAlD
Amisulpride—HTR2A—cardiovascular system—coronary artery disease	0.000531	0.00607	CbGeAlD
Amisulpride—HTR2A—blood—coronary artery disease	0.00042	0.0048	CbGeAlD
Amisulpride—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000168	0.000787	CcSEcCtD
Amisulpride—Hyperhidrosis—Losartan—coronary artery disease	0.000168	0.000786	CcSEcCtD
Amisulpride—Dyspepsia—Captopril—coronary artery disease	0.000168	0.000786	CcSEcCtD
Amisulpride—Constipation—Telmisartan—coronary artery disease	0.000167	0.000785	CcSEcCtD
Amisulpride—Agitation—Ramipril—coronary artery disease	0.000167	0.000785	CcSEcCtD
Amisulpride—Hypersensitivity—Simvastatin—coronary artery disease	0.000167	0.000784	CcSEcCtD
Amisulpride—Insomnia—Perindopril—coronary artery disease	0.000167	0.000784	CcSEcCtD
Amisulpride—Diarrhoea—Clopidogrel—coronary artery disease	0.000167	0.000784	CcSEcCtD
Amisulpride—Asthenia—Eplerenone—coronary artery disease	0.000167	0.000784	CcSEcCtD
Amisulpride—Angioedema—Ramipril—coronary artery disease	0.000166	0.00078	CcSEcCtD
Amisulpride—Mental disorder—Lisinopril—coronary artery disease	0.000166	0.000779	CcSEcCtD
Amisulpride—Diarrhoea—Lovastatin—coronary artery disease	0.000166	0.000778	CcSEcCtD
Amisulpride—Urticaria—Niacin—coronary artery disease	0.000166	0.000776	CcSEcCtD
Amisulpride—Nausea—Acetylsalicylic acid—coronary artery disease	0.000165	0.000775	CcSEcCtD
Amisulpride—Malnutrition—Lisinopril—coronary artery disease	0.000165	0.000775	CcSEcCtD
Amisulpride—Pruritus—Eplerenone—coronary artery disease	0.000165	0.000773	CcSEcCtD
Amisulpride—Abdominal pain—Niacin—coronary artery disease	0.000165	0.000773	CcSEcCtD
Amisulpride—Dizziness—Fenofibrate—coronary artery disease	0.000164	0.000771	CcSEcCtD
Amisulpride—Somnolence—Perindopril—coronary artery disease	0.000164	0.00077	CcSEcCtD
Amisulpride—Fatigue—Captopril—coronary artery disease	0.000164	0.00077	CcSEcCtD
Amisulpride—Leukopenia—Ramipril—coronary artery disease	0.000163	0.000764	CcSEcCtD
Amisulpride—Urticaria—Pravastatin—coronary artery disease	0.000163	0.000764	CcSEcCtD
Amisulpride—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000163	0.000764	CcSEcCtD
Amisulpride—Asthenia—Simvastatin—coronary artery disease	0.000163	0.000764	CcSEcCtD
Amisulpride—Diarrhoea—Ezetimibe—coronary artery disease	0.000163	0.000764	CcSEcCtD
Amisulpride—Constipation—Captopril—coronary artery disease	0.000163	0.000763	CcSEcCtD
Amisulpride—Angioedema—Timolol—coronary artery disease	0.000163	0.000763	CcSEcCtD
Amisulpride—Dyspepsia—Perindopril—coronary artery disease	0.000163	0.000763	CcSEcCtD
Amisulpride—Gastrointestinal pain—Enalapril—coronary artery disease	0.000162	0.000761	CcSEcCtD
Amisulpride—Abdominal pain—Pravastatin—coronary artery disease	0.000162	0.000761	CcSEcCtD
Amisulpride—Tension—Lisinopril—coronary artery disease	0.000162	0.00076	CcSEcCtD
Amisulpride—Hypotension—Losartan—coronary artery disease	0.000162	0.00076	CcSEcCtD
Amisulpride—Dizziness—Clopidogrel—coronary artery disease	0.000162	0.000757	CcSEcCtD
Amisulpride—Pruritus—Simvastatin—coronary artery disease	0.000161	0.000753	CcSEcCtD
Amisulpride—Dizziness—Lovastatin—coronary artery disease	0.00016	0.000752	CcSEcCtD
Amisulpride—Nervousness—Lisinopril—coronary artery disease	0.00016	0.000752	CcSEcCtD
Amisulpride—Gastrointestinal pain—Telmisartan—coronary artery disease	0.00016	0.000751	CcSEcCtD
Amisulpride—Somnolence—Furosemide—coronary artery disease	0.00016	0.000749	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00016	0.000748	CcSEcCtD
Amisulpride—Diarrhoea—Eplerenone—coronary artery disease	0.000159	0.000747	CcSEcCtD
Amisulpride—Fatigue—Perindopril—coronary artery disease	0.000159	0.000747	CcSEcCtD
Amisulpride—Muscle spasms—Lisinopril—coronary artery disease	0.000159	0.000745	CcSEcCtD
Amisulpride—Urticaria—Trandolapril—coronary artery disease	0.000158	0.000742	CcSEcCtD
Amisulpride—Constipation—Perindopril—coronary artery disease	0.000158	0.000741	CcSEcCtD
Amisulpride—Vomiting—Fenofibrate—coronary artery disease	0.000158	0.000741	CcSEcCtD
Amisulpride—Hypersensitivity—Valsartan—coronary artery disease	0.000158	0.00074	CcSEcCtD
Amisulpride—Convulsion—Ramipril—coronary artery disease	0.000158	0.00074	CcSEcCtD
Amisulpride—Urticaria—Enalapril—coronary artery disease	0.000158	0.000739	CcSEcCtD
Amisulpride—Abdominal pain—Trandolapril—coronary artery disease	0.000158	0.000739	CcSEcCtD
Amisulpride—Dizziness—Ezetimibe—coronary artery disease	0.000157	0.000738	CcSEcCtD
Amisulpride—Abdominal pain—Enalapril—coronary artery disease	0.000157	0.000736	CcSEcCtD
Amisulpride—Insomnia—Losartan—coronary artery disease	0.000157	0.000735	CcSEcCtD
Amisulpride—Headache—Fenofibrate—coronary artery disease	0.000156	0.00073	CcSEcCtD
Amisulpride—Gastrointestinal pain—Captopril—coronary artery disease	0.000156	0.00073	CcSEcCtD
Amisulpride—Urticaria—Telmisartan—coronary artery disease	0.000156	0.000729	CcSEcCtD
Amisulpride—Vomiting—Clopidogrel—coronary artery disease	0.000155	0.000728	CcSEcCtD
Amisulpride—Diarrhoea—Simvastatin—coronary artery disease	0.000155	0.000728	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000155	0.000727	CcSEcCtD
Amisulpride—Fatigue—Furosemide—coronary artery disease	0.000155	0.000726	CcSEcCtD
Amisulpride—Tremor—Lisinopril—coronary artery disease	0.000155	0.000726	CcSEcCtD
Amisulpride—Abdominal pain—Telmisartan—coronary artery disease	0.000155	0.000726	CcSEcCtD
Amisulpride—Anxiety—Ramipril—coronary artery disease	0.000155	0.000725	CcSEcCtD
Amisulpride—Vomiting—Lovastatin—coronary artery disease	0.000154	0.000723	CcSEcCtD
Amisulpride—Somnolence—Losartan—coronary artery disease	0.000154	0.000723	CcSEcCtD
Amisulpride—Dizziness—Eplerenone—coronary artery disease	0.000154	0.000722	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000154	0.000722	CcSEcCtD
Amisulpride—Asthenia—Valsartan—coronary artery disease	0.000154	0.000721	CcSEcCtD
Amisulpride—Hypertension—Timolol—coronary artery disease	0.000154	0.000721	CcSEcCtD
Amisulpride—Constipation—Furosemide—coronary artery disease	0.000154	0.00072	CcSEcCtD
Amisulpride—Hypersensitivity—Niacin—coronary artery disease	0.000154	0.00072	CcSEcCtD
Amisulpride—Asthenia—Olmesartan—coronary artery disease	0.000153	0.000718	CcSEcCtD
Amisulpride—Headache—Clopidogrel—coronary artery disease	0.000153	0.000718	CcSEcCtD
Amisulpride—Dyspepsia—Losartan—coronary artery disease	0.000153	0.000716	CcSEcCtD
Amisulpride—Headache—Lovastatin—coronary artery disease	0.000152	0.000713	CcSEcCtD
Amisulpride—Pruritus—Valsartan—coronary artery disease	0.000152	0.000711	CcSEcCtD
Amisulpride—Dry mouth—Ramipril—coronary artery disease	0.000152	0.000711	CcSEcCtD
Amisulpride—Vomiting—Ezetimibe—coronary artery disease	0.000151	0.00071	CcSEcCtD
Amisulpride—Hypersensitivity—Pravastatin—coronary artery disease	0.000151	0.000709	CcSEcCtD
Amisulpride—Gastrointestinal pain—Perindopril—coronary artery disease	0.000151	0.000709	CcSEcCtD
Amisulpride—Anxiety—Timolol—coronary artery disease	0.000151	0.000708	CcSEcCtD
Amisulpride—Angioedema—Lisinopril—coronary artery disease	0.000151	0.000708	CcSEcCtD
Amisulpride—Pruritus—Olmesartan—coronary artery disease	0.000151	0.000708	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000151	0.000706	CcSEcCtD
Amisulpride—Abdominal pain—Captopril—coronary artery disease	0.00015	0.000706	CcSEcCtD
Amisulpride—Dizziness—Simvastatin—coronary artery disease	0.00015	0.000704	CcSEcCtD
Amisulpride—Asthenia—Niacin—coronary artery disease	0.00015	0.000701	CcSEcCtD
Amisulpride—Fatigue—Losartan—coronary artery disease	0.000149	0.000701	CcSEcCtD
Amisulpride—Headache—Ezetimibe—coronary artery disease	0.000149	0.000699	CcSEcCtD
Amisulpride—Dry mouth—Timolol—coronary artery disease	0.000148	0.000695	CcSEcCtD
Amisulpride—Constipation—Losartan—coronary artery disease	0.000148	0.000695	CcSEcCtD
Amisulpride—Vomiting—Eplerenone—coronary artery disease	0.000148	0.000694	CcSEcCtD
Amisulpride—Leukopenia—Lisinopril—coronary artery disease	0.000148	0.000693	CcSEcCtD
Amisulpride—Nausea—Fenofibrate—coronary artery disease	0.000148	0.000692	CcSEcCtD
Amisulpride—Pruritus—Niacin—coronary artery disease	0.000147	0.000691	CcSEcCtD
Amisulpride—Asthenia—Pravastatin—coronary artery disease	0.000147	0.00069	CcSEcCtD
Amisulpride—Gastrointestinal pain—Furosemide—coronary artery disease	0.000147	0.000689	CcSEcCtD
Amisulpride—Urticaria—Perindopril—coronary artery disease	0.000147	0.000688	CcSEcCtD
Amisulpride—Hypersensitivity—Trandolapril—coronary artery disease	0.000147	0.000688	CcSEcCtD
Amisulpride—Diarrhoea—Valsartan—coronary artery disease	0.000147	0.000688	CcSEcCtD
Amisulpride—Hypersensitivity—Enalapril—coronary artery disease	0.000146	0.000686	CcSEcCtD
Amisulpride—Abdominal pain—Perindopril—coronary artery disease	0.000146	0.000685	CcSEcCtD
Amisulpride—Diarrhoea—Olmesartan—coronary artery disease	0.000146	0.000684	CcSEcCtD
Amisulpride—Headache—Eplerenone—coronary artery disease	0.000146	0.000684	CcSEcCtD
Amisulpride—Nervous system disorder—Ramipril—coronary artery disease	0.000146	0.000684	CcSEcCtD
Amisulpride—Pruritus—Pravastatin—coronary artery disease	0.000145	0.000681	CcSEcCtD
Amisulpride—Nausea—Clopidogrel—coronary artery disease	0.000145	0.00068	CcSEcCtD
Amisulpride—Skin disorder—Ramipril—coronary artery disease	0.000144	0.000677	CcSEcCtD
Amisulpride—Vomiting—Simvastatin—coronary artery disease	0.000144	0.000677	CcSEcCtD
Amisulpride—Hypersensitivity—Telmisartan—coronary artery disease	0.000144	0.000676	CcSEcCtD
Amisulpride—Nausea—Lovastatin—coronary artery disease	0.000144	0.000676	CcSEcCtD
Amisulpride—Hyperhidrosis—Ramipril—coronary artery disease	0.000144	0.000674	CcSEcCtD
Amisulpride—Asthenia—Trandolapril—coronary artery disease	0.000143	0.00067	CcSEcCtD
Amisulpride—Urticaria—Furosemide—coronary artery disease	0.000143	0.000669	CcSEcCtD
Amisulpride—Diarrhoea—Niacin—coronary artery disease	0.000143	0.000669	CcSEcCtD
Amisulpride—Nervous system disorder—Timolol—coronary artery disease	0.000143	0.000668	CcSEcCtD
Amisulpride—Asthenia—Enalapril—coronary artery disease	0.000142	0.000668	CcSEcCtD
Amisulpride—Headache—Simvastatin—coronary artery disease	0.000142	0.000667	CcSEcCtD
Amisulpride—Abdominal pain—Furosemide—coronary artery disease	0.000142	0.000666	CcSEcCtD
Amisulpride—Gastrointestinal pain—Losartan—coronary artery disease	0.000142	0.000665	CcSEcCtD
Amisulpride—Dizziness—Valsartan—coronary artery disease	0.000142	0.000665	CcSEcCtD
Amisulpride—Nausea—Ezetimibe—coronary artery disease	0.000141	0.000663	CcSEcCtD
Amisulpride—Skin disorder—Timolol—coronary artery disease	0.000141	0.000662	CcSEcCtD
Amisulpride—Dizziness—Olmesartan—coronary artery disease	0.000141	0.000661	CcSEcCtD
Amisulpride—Pruritus—Trandolapril—coronary artery disease	0.000141	0.000661	CcSEcCtD
Amisulpride—Hyperhidrosis—Timolol—coronary artery disease	0.00014	0.000659	CcSEcCtD
Amisulpride—Asthenia—Telmisartan—coronary artery disease	0.00014	0.000659	CcSEcCtD
Amisulpride—Pruritus—Enalapril—coronary artery disease	0.00014	0.000658	CcSEcCtD
Amisulpride—Diarrhoea—Pravastatin—coronary artery disease	0.00014	0.000658	CcSEcCtD
Amisulpride—Anxiety—Lisinopril—coronary artery disease	0.00014	0.000657	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.00014	0.000655	CcSEcCtD
Amisulpride—Hypotension—Ramipril—coronary artery disease	0.000139	0.000651	CcSEcCtD
Amisulpride—Pruritus—Telmisartan—coronary artery disease	0.000138	0.000649	CcSEcCtD
Amisulpride—Nausea—Eplerenone—coronary artery disease	0.000138	0.000649	CcSEcCtD
Amisulpride—Dizziness—Niacin—coronary artery disease	0.000138	0.000646	CcSEcCtD
Amisulpride—Urticaria—Losartan—coronary artery disease	0.000138	0.000646	CcSEcCtD
Amisulpride—Dry mouth—Lisinopril—coronary artery disease	0.000138	0.000645	CcSEcCtD
Amisulpride—Abdominal pain—Losartan—coronary artery disease	0.000137	0.000643	CcSEcCtD
Amisulpride—Asthenia—Captopril—coronary artery disease	0.000137	0.00064	CcSEcCtD
Amisulpride—Diarrhoea—Trandolapril—coronary artery disease	0.000136	0.000639	CcSEcCtD
Amisulpride—Vomiting—Valsartan—coronary artery disease	0.000136	0.000639	CcSEcCtD
Amisulpride—Diarrhoea—Enalapril—coronary artery disease	0.000136	0.000637	CcSEcCtD
Amisulpride—Hypotension—Timolol—coronary artery disease	0.000136	0.000637	CcSEcCtD
Amisulpride—Dizziness—Pravastatin—coronary artery disease	0.000136	0.000636	CcSEcCtD
Amisulpride—Vomiting—Olmesartan—coronary artery disease	0.000136	0.000636	CcSEcCtD
Amisulpride—Nausea—Simvastatin—coronary artery disease	0.000135	0.000632	CcSEcCtD
Amisulpride—Pruritus—Captopril—coronary artery disease	0.000135	0.000631	CcSEcCtD
Amisulpride—Insomnia—Ramipril—coronary artery disease	0.000134	0.00063	CcSEcCtD
Amisulpride—Headache—Valsartan—coronary artery disease	0.000134	0.00063	CcSEcCtD
Amisulpride—Diarrhoea—Telmisartan—coronary artery disease	0.000134	0.000628	CcSEcCtD
Amisulpride—Headache—Olmesartan—coronary artery disease	0.000134	0.000627	CcSEcCtD
Amisulpride—Asthenia—Perindopril—coronary artery disease	0.000133	0.000622	CcSEcCtD
Amisulpride—Vomiting—Niacin—coronary artery disease	0.000133	0.000621	CcSEcCtD
Amisulpride—Hypersensitivity—Furosemide—coronary artery disease	0.000132	0.000621	CcSEcCtD
Amisulpride—Somnolence—Ramipril—coronary artery disease	0.000132	0.00062	CcSEcCtD
Amisulpride—Dizziness—Trandolapril—coronary artery disease	0.000132	0.000618	CcSEcCtD
Amisulpride—Insomnia—Timolol—coronary artery disease	0.000131	0.000616	CcSEcCtD
Amisulpride—Dizziness—Enalapril—coronary artery disease	0.000131	0.000615	CcSEcCtD
Amisulpride—Skin disorder—Lisinopril—coronary artery disease	0.000131	0.000614	CcSEcCtD
Amisulpride—Dyspepsia—Ramipril—coronary artery disease	0.000131	0.000614	CcSEcCtD
Amisulpride—Pruritus—Perindopril—coronary artery disease	0.000131	0.000613	CcSEcCtD
Amisulpride—Headache—Niacin—coronary artery disease	0.000131	0.000612	CcSEcCtD
Amisulpride—Vomiting—Pravastatin—coronary artery disease	0.00013	0.000612	CcSEcCtD
Amisulpride—Hyperhidrosis—Lisinopril—coronary artery disease	0.00013	0.000611	CcSEcCtD
Amisulpride—Diarrhoea—Captopril—coronary artery disease	0.00013	0.000611	CcSEcCtD
Amisulpride—Dizziness—Telmisartan—coronary artery disease	0.000129	0.000607	CcSEcCtD
Amisulpride—Somnolence—Timolol—coronary artery disease	0.000129	0.000606	CcSEcCtD
Amisulpride—Asthenia—Furosemide—coronary artery disease	0.000129	0.000604	CcSEcCtD
Amisulpride—Headache—Pravastatin—coronary artery disease	0.000129	0.000603	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000128	0.000602	CcSEcCtD
Amisulpride—Fatigue—Ramipril—coronary artery disease	0.000128	0.000601	CcSEcCtD
Amisulpride—Dyspepsia—Timolol—coronary artery disease	0.000128	0.0006	CcSEcCtD
Amisulpride—Hypersensitivity—Losartan—coronary artery disease	0.000128	0.000599	CcSEcCtD
Amisulpride—Nausea—Valsartan—coronary artery disease	0.000127	0.000597	CcSEcCtD
Amisulpride—Pruritus—Furosemide—coronary artery disease	0.000127	0.000596	CcSEcCtD
Amisulpride—Constipation—Ramipril—coronary artery disease	0.000127	0.000596	CcSEcCtD
Amisulpride—Nausea—Olmesartan—coronary artery disease	0.000127	0.000594	CcSEcCtD
Amisulpride—Vomiting—Trandolapril—coronary artery disease	0.000127	0.000594	CcSEcCtD
Amisulpride—Diarrhoea—Perindopril—coronary artery disease	0.000126	0.000593	CcSEcCtD
Amisulpride—Vomiting—Enalapril—coronary artery disease	0.000126	0.000592	CcSEcCtD
Amisulpride—Hypotension—Lisinopril—coronary artery disease	0.000126	0.000591	CcSEcCtD
Amisulpride—Dizziness—Captopril—coronary artery disease	0.000126	0.00059	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Timolol—coronary artery disease	0.000125	0.000588	CcSEcCtD
Amisulpride—Fatigue—Timolol—coronary artery disease	0.000125	0.000587	CcSEcCtD
Amisulpride—Headache—Trandolapril—coronary artery disease	0.000125	0.000585	CcSEcCtD
Amisulpride—Vomiting—Telmisartan—coronary artery disease	0.000124	0.000584	CcSEcCtD
Amisulpride—Asthenia—Losartan—coronary artery disease	0.000124	0.000583	CcSEcCtD
Amisulpride—Headache—Enalapril—coronary artery disease	0.000124	0.000583	CcSEcCtD
Amisulpride—Nausea—Niacin—coronary artery disease	0.000124	0.00058	CcSEcCtD
Amisulpride—Diarrhoea—Furosemide—coronary artery disease	0.000123	0.000576	CcSEcCtD
Amisulpride—Pruritus—Losartan—coronary artery disease	0.000123	0.000575	CcSEcCtD
Amisulpride—Headache—Telmisartan—coronary artery disease	0.000123	0.000575	CcSEcCtD
Amisulpride—Dizziness—Perindopril—coronary artery disease	0.000122	0.000573	CcSEcCtD
Amisulpride—Insomnia—Lisinopril—coronary artery disease	0.000122	0.000572	CcSEcCtD
Amisulpride—Nausea—Pravastatin—coronary artery disease	0.000122	0.000572	CcSEcCtD
Amisulpride—Gastrointestinal pain—Ramipril—coronary artery disease	0.000122	0.00057	CcSEcCtD
Amisulpride—Vomiting—Captopril—coronary artery disease	0.000121	0.000568	CcSEcCtD
Amisulpride—Somnolence—Lisinopril—coronary artery disease	0.00012	0.000562	CcSEcCtD
Amisulpride—Headache—Captopril—coronary artery disease	0.000119	0.000559	CcSEcCtD
Amisulpride—Gastrointestinal pain—Timolol—coronary artery disease	0.000119	0.000557	CcSEcCtD
Amisulpride—Dizziness—Furosemide—coronary artery disease	0.000119	0.000557	CcSEcCtD
Amisulpride—Dyspepsia—Lisinopril—coronary artery disease	0.000119	0.000556	CcSEcCtD
Amisulpride—Diarrhoea—Losartan—coronary artery disease	0.000119	0.000556	CcSEcCtD
Amisulpride—Nausea—Trandolapril—coronary artery disease	0.000118	0.000555	CcSEcCtD
Amisulpride—Urticaria—Ramipril—coronary artery disease	0.000118	0.000554	CcSEcCtD
Amisulpride—Nausea—Enalapril—coronary artery disease	0.000118	0.000553	CcSEcCtD
Amisulpride—Vomiting—Perindopril—coronary artery disease	0.000118	0.000551	CcSEcCtD
Amisulpride—Abdominal pain—Ramipril—coronary artery disease	0.000118	0.000551	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000116	0.000546	CcSEcCtD
Amisulpride—Nausea—Telmisartan—coronary artery disease	0.000116	0.000545	CcSEcCtD
Amisulpride—Fatigue—Lisinopril—coronary artery disease	0.000116	0.000545	CcSEcCtD
Amisulpride—Headache—Perindopril—coronary artery disease	0.000116	0.000543	CcSEcCtD
Amisulpride—Urticaria—Timolol—coronary artery disease	0.000115	0.000541	CcSEcCtD
Amisulpride—Constipation—Lisinopril—coronary artery disease	0.000115	0.000541	CcSEcCtD
Amisulpride—Abdominal pain—Timolol—coronary artery disease	0.000115	0.000539	CcSEcCtD
Amisulpride—Dizziness—Losartan—coronary artery disease	0.000115	0.000538	CcSEcCtD
Amisulpride—Vomiting—Furosemide—coronary artery disease	0.000114	0.000536	CcSEcCtD
Amisulpride—Nausea—Captopril—coronary artery disease	0.000113	0.00053	CcSEcCtD
Amisulpride—Headache—Furosemide—coronary artery disease	0.000113	0.000528	CcSEcCtD
Amisulpride—Gastrointestinal pain—Lisinopril—coronary artery disease	0.00011	0.000517	CcSEcCtD
Amisulpride—Vomiting—Losartan—coronary artery disease	0.00011	0.000517	CcSEcCtD
Amisulpride—Nausea—Perindopril—coronary artery disease	0.00011	0.000515	CcSEcCtD
Amisulpride—Hypersensitivity—Ramipril—coronary artery disease	0.00011	0.000514	CcSEcCtD
Amisulpride—Headache—Losartan—coronary artery disease	0.000109	0.000509	CcSEcCtD
Amisulpride—Urticaria—Lisinopril—coronary artery disease	0.000107	0.000502	CcSEcCtD
Amisulpride—Hypersensitivity—Timolol—coronary artery disease	0.000107	0.000502	CcSEcCtD
Amisulpride—Nausea—Furosemide—coronary artery disease	0.000107	0.0005	CcSEcCtD
Amisulpride—Asthenia—Ramipril—coronary artery disease	0.000107	0.0005	CcSEcCtD
Amisulpride—Abdominal pain—Lisinopril—coronary artery disease	0.000107	0.0005	CcSEcCtD
Amisulpride—Pruritus—Ramipril—coronary artery disease	0.000105	0.000493	CcSEcCtD
Amisulpride—Asthenia—Timolol—coronary artery disease	0.000104	0.000489	CcSEcCtD
Amisulpride—Nausea—Losartan—coronary artery disease	0.000103	0.000483	CcSEcCtD
Amisulpride—Pruritus—Timolol—coronary artery disease	0.000103	0.000482	CcSEcCtD
Amisulpride—Diarrhoea—Ramipril—coronary artery disease	0.000102	0.000477	CcSEcCtD
Amisulpride—Diarrhoea—Timolol—coronary artery disease	9.94e-05	0.000466	CcSEcCtD
Amisulpride—Hypersensitivity—Lisinopril—coronary artery disease	9.93e-05	0.000466	CcSEcCtD
Amisulpride—Dizziness—Ramipril—coronary artery disease	9.83e-05	0.000461	CcSEcCtD
Amisulpride—Asthenia—Lisinopril—coronary artery disease	9.67e-05	0.000454	CcSEcCtD
Amisulpride—Dizziness—Timolol—coronary artery disease	9.61e-05	0.000451	CcSEcCtD
Amisulpride—Pruritus—Lisinopril—coronary artery disease	9.54e-05	0.000447	CcSEcCtD
Amisulpride—Vomiting—Ramipril—coronary artery disease	9.45e-05	0.000443	CcSEcCtD
Amisulpride—Headache—Ramipril—coronary artery disease	9.31e-05	0.000437	CcSEcCtD
Amisulpride—Vomiting—Timolol—coronary artery disease	9.24e-05	0.000433	CcSEcCtD
Amisulpride—Diarrhoea—Lisinopril—coronary artery disease	9.22e-05	0.000432	CcSEcCtD
Amisulpride—Headache—Timolol—coronary artery disease	9.1e-05	0.000427	CcSEcCtD
Amisulpride—Dizziness—Lisinopril—coronary artery disease	8.91e-05	0.000418	CcSEcCtD
Amisulpride—Nausea—Ramipril—coronary artery disease	8.83e-05	0.000414	CcSEcCtD
Amisulpride—Nausea—Timolol—coronary artery disease	8.63e-05	0.000405	CcSEcCtD
Amisulpride—Vomiting—Lisinopril—coronary artery disease	8.57e-05	0.000402	CcSEcCtD
Amisulpride—Headache—Lisinopril—coronary artery disease	8.44e-05	0.000396	CcSEcCtD
Amisulpride—Nausea—Lisinopril—coronary artery disease	8.01e-05	0.000375	CcSEcCtD
Amisulpride—HTR2B—Signaling Pathways—HIF1A—coronary artery disease	9.28e-06	7.78e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PRKCD—coronary artery disease	9.27e-06	7.76e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KNG1—coronary artery disease	9.26e-06	7.76e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGT—coronary artery disease	9.25e-06	7.75e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NFKBIA—coronary artery disease	9.24e-06	7.74e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—POMC—coronary artery disease	9.23e-06	7.73e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CREB1—coronary artery disease	9.23e-06	7.73e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGTR1—coronary artery disease	9.2e-06	7.71e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL2—coronary artery disease	9.18e-06	7.69e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6R—coronary artery disease	9.15e-06	7.67e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL10—coronary artery disease	9.14e-06	7.66e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PLG—coronary artery disease	9.12e-06	7.64e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HTR2A—coronary artery disease	9.07e-06	7.6e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOE—coronary artery disease	9.06e-06	7.59e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LEP—coronary artery disease	9.06e-06	7.59e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—C3—coronary artery disease	9.05e-06	7.59e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL2—coronary artery disease	9.03e-06	7.57e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6R—coronary artery disease	9e-06	7.54e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL10—coronary artery disease	9e-06	7.54e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PLG—coronary artery disease	8.97e-06	7.52e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOA1—coronary artery disease	8.96e-06	7.5e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KIT—coronary artery disease	8.95e-06	7.5e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KDR—coronary artery disease	8.88e-06	7.44e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADRB2—coronary artery disease	8.88e-06	7.44e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK14—coronary artery disease	8.82e-06	7.39e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKCE—coronary artery disease	8.76e-06	7.34e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—JAK2—coronary artery disease	8.75e-06	7.34e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SOCS1—coronary artery disease	8.74e-06	7.32e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADRB2—coronary artery disease	8.73e-06	7.32e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—S100B—coronary artery disease	8.72e-06	7.31e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ESR1—coronary artery disease	8.65e-06	7.25e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HIF1A—coronary artery disease	8.64e-06	7.24e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SOCS3—coronary artery disease	8.63e-06	7.23e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKCE—coronary artery disease	8.62e-06	7.22e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—JAK2—coronary artery disease	8.61e-06	7.22e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGT—coronary artery disease	8.6e-06	7.21e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SOCS1—coronary artery disease	8.6e-06	7.21e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—GSK3B—coronary artery disease	8.59e-06	7.19e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—S100B—coronary artery disease	8.58e-06	7.19e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—F2—coronary artery disease	8.54e-06	7.16e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FN1—coronary artery disease	8.54e-06	7.16e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFBR2—coronary artery disease	8.53e-06	7.15e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KITLG—coronary artery disease	8.53e-06	7.15e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—POMC—coronary artery disease	8.52e-06	7.14e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CREB1—coronary artery disease	8.52e-06	7.14e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6ST—coronary artery disease	8.51e-06	7.13e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SOCS3—coronary artery disease	8.49e-06	7.12e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NFKBIA—coronary artery disease	8.44e-06	7.07e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOE—coronary artery disease	8.43e-06	7.06e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LEP—coronary artery disease	8.43e-06	7.06e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KITLG—coronary artery disease	8.39e-06	7.03e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFBR2—coronary artery disease	8.39e-06	7.03e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT5A—coronary artery disease	8.34e-06	6.99e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP3—coronary artery disease	8.34e-06	6.99e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL2—coronary artery disease	8.33e-06	6.98e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOA1—coronary artery disease	8.33e-06	6.98e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6R—coronary artery disease	8.31e-06	6.96e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KDR—coronary artery disease	8.26e-06	6.92e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP3—coronary artery disease	8.2e-06	6.87e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT5A—coronary artery disease	8.2e-06	6.87e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK14—coronary artery disease	8.2e-06	6.87e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IGF1—coronary artery disease	8.19e-06	6.86e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KIT—coronary artery disease	8.18e-06	6.85e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—MAPK1—coronary artery disease	8.15e-06	6.83e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOB—coronary artery disease	8.06e-06	6.75e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ESR1—coronary artery disease	8.05e-06	6.74e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCL8—coronary artery disease	7.99e-06	6.7e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—JAK2—coronary artery disease	7.95e-06	6.66e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—F2—coronary artery disease	7.95e-06	6.66e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FN1—coronary artery disease	7.95e-06	6.66e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EDN1—coronary artery disease	7.93e-06	6.65e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOB—coronary artery disease	7.93e-06	6.64e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6ST—coronary artery disease	7.92e-06	6.63e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL5—coronary artery disease	7.87e-06	6.59e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL8—coronary artery disease	7.86e-06	6.59e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NFKBIA—coronary artery disease	7.85e-06	6.58e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—GSK3B—coronary artery disease	7.85e-06	6.57e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—JAK2—coronary artery disease	7.82e-06	6.55e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EDN1—coronary artery disease	7.8e-06	6.54e-05	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—PIK3CA—coronary artery disease	7.79e-06	6.53e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CREB1—coronary artery disease	7.78e-06	6.52e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—POMC—coronary artery disease	7.78e-06	6.52e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SERPINE1—coronary artery disease	7.78e-06	6.52e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CSF2—coronary artery disease	7.75e-06	6.5e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGF1—coronary artery disease	7.75e-06	6.5e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL5—coronary artery disease	7.74e-06	6.49e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LPL—coronary artery disease	7.7e-06	6.45e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGF1—coronary artery disease	7.63e-06	6.39e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CSF2—coronary artery disease	7.63e-06	6.39e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MEF2C—coronary artery disease	7.63e-06	6.39e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RPS6KB1—coronary artery disease	7.63e-06	6.39e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL2—coronary artery disease	7.61e-06	6.38e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KIT—coronary artery disease	7.61e-06	6.37e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6R—coronary artery disease	7.59e-06	6.36e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LPL—coronary artery disease	7.57e-06	6.34e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FGF2—coronary artery disease	7.53e-06	6.31e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RPS6KB1—coronary artery disease	7.5e-06	6.29e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MEF2C—coronary artery disease	7.5e-06	6.29e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF1—coronary artery disease	7.49e-06	6.27e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—MAPK1—coronary artery disease	7.45e-06	6.24e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ITGB3—coronary artery disease	7.43e-06	6.23e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NOS3—coronary artery disease	7.43e-06	6.22e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ITGB3—coronary artery disease	7.31e-06	6.13e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—GSK3B—coronary artery disease	7.3e-06	6.12e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL8—coronary artery disease	7.26e-06	6.08e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—POMC—coronary artery disease	7.24e-06	6.07e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CREB1—coronary artery disease	7.24e-06	6.07e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PPP2CA—coronary artery disease	7.22e-06	6.05e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—JAK2—coronary artery disease	7.22e-06	6.05e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL8—coronary artery disease	7.14e-06	5.98e-05	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CA—coronary artery disease	7.12e-06	5.97e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SERPINE1—coronary artery disease	7.11e-06	5.96e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PPP2CA—coronary artery disease	7.1e-06	5.95e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKCD—coronary artery disease	7.09e-06	5.94e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL2—coronary artery disease	7.09e-06	5.94e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CA—coronary artery disease	7.07e-06	5.93e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6R—coronary artery disease	7.06e-06	5.92e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKCD—coronary artery disease	6.98e-06	5.85e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1—coronary artery disease	6.97e-06	5.84e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HTR2A—coronary artery disease	6.94e-06	5.81e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—MAPK1—coronary artery disease	6.93e-06	5.81e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—C3—coronary artery disease	6.93e-06	5.81e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGF2—coronary artery disease	6.88e-06	5.77e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—C3—coronary artery disease	6.82e-06	5.71e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NOS3—coronary artery disease	6.79e-06	5.69e-05	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CA—coronary artery disease	6.62e-06	5.55e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SERPINE1—coronary artery disease	6.61e-06	5.54e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HIF1A—coronary artery disease	6.61e-06	5.54e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—JAK2—coronary artery disease	6.6e-06	5.53e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL8—coronary artery disease	6.59e-06	5.52e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGT—coronary artery disease	6.58e-06	5.52e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HIF1A—coronary artery disease	6.5e-06	5.45e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGT—coronary artery disease	6.48e-06	5.43e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CA—coronary artery disease	6.46e-06	5.42e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOE—coronary artery disease	6.45e-06	5.4e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LEP—coronary artery disease	6.45e-06	5.4e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGF2—coronary artery disease	6.4e-06	5.37e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOA1—coronary artery disease	6.38e-06	5.34e-05	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—coronary artery disease	6.36e-06	5.33e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LEP—coronary artery disease	6.35e-06	5.32e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOE—coronary artery disease	6.35e-06	5.32e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KDR—coronary artery disease	6.32e-06	5.3e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NOS3—coronary artery disease	6.32e-06	5.29e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—coronary artery disease	6.31e-06	5.28e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK14—coronary artery disease	6.28e-06	5.26e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOA1—coronary artery disease	6.27e-06	5.26e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—coronary artery disease	6.26e-06	5.25e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KDR—coronary artery disease	6.22e-06	5.21e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	6.18e-06	5.18e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ESR1—coronary artery disease	6.16e-06	5.16e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCND1—coronary artery disease	6.14e-06	5.14e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—JAK2—coronary artery disease	6.14e-06	5.14e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—F2—coronary artery disease	6.08e-06	5.1e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FN1—coronary artery disease	6.08e-06	5.1e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ESR1—coronary artery disease	6.06e-06	5.08e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6ST—coronary artery disease	6.06e-06	5.08e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL8—coronary artery disease	6.02e-06	5.04e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CA—coronary artery disease	6.02e-06	5.04e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	6.01e-06	5.04e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—F2—coronary artery disease	5.99e-06	5.02e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FN1—coronary artery disease	5.99e-06	5.02e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	5.96e-06	5e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—coronary artery disease	5.96e-06	4.99e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	5.91e-06	4.96e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KIT—coronary artery disease	5.82e-06	4.88e-05	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—coronary artery disease	5.82e-06	4.87e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—coronary artery disease	5.78e-06	4.84e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—coronary artery disease	5.76e-06	4.83e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KIT—coronary artery disease	5.73e-06	4.8e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—coronary artery disease	5.72e-06	4.8e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCND1—coronary artery disease	5.61e-06	4.7e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL8—coronary artery disease	5.6e-06	4.69e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GSK3B—coronary artery disease	5.59e-06	4.68e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—POMC—coronary artery disease	5.54e-06	4.64e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CREB1—coronary artery disease	5.54e-06	4.64e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	5.5e-06	4.61e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—POMC—coronary artery disease	5.45e-06	4.57e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CREB1—coronary artery disease	5.45e-06	4.57e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—coronary artery disease	5.45e-06	4.56e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL2—coronary artery disease	5.42e-06	4.54e-05	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—coronary artery disease	5.41e-06	4.53e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6R—coronary artery disease	5.41e-06	4.53e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—coronary artery disease	5.36e-06	4.49e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—coronary artery disease	5.35e-06	4.48e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL2—coronary artery disease	5.33e-06	4.47e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1—coronary artery disease	5.33e-06	4.47e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—coronary artery disease	5.33e-06	4.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6R—coronary artery disease	5.32e-06	4.46e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	5.3e-06	4.44e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	5.28e-06	4.43e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1—coronary artery disease	5.24e-06	4.39e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	5.22e-06	4.37e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCND1—coronary artery disease	5.22e-06	4.37e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	5.07e-06	4.25e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—coronary artery disease	5.07e-06	4.25e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	5.06e-06	4.24e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.99e-06	4.18e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	4.98e-06	4.17e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—coronary artery disease	4.91e-06	4.12e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—coronary artery disease	4.91e-06	4.12e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGF2—coronary artery disease	4.9e-06	4.11e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	4.89e-06	4.1e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOS3—coronary artery disease	4.83e-06	4.05e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGF2—coronary artery disease	4.82e-06	4.04e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK1—coronary artery disease	4.82e-06	4.04e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOS3—coronary artery disease	4.75e-06	3.98e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JAK2—coronary artery disease	4.7e-06	3.94e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JAK2—coronary artery disease	4.62e-06	3.87e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	4.6e-06	3.86e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—coronary artery disease	4.55e-06	3.81e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	4.53e-06	3.8e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	4.49e-06	3.76e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	4.4e-06	3.69e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL8—coronary artery disease	4.29e-06	3.59e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	4.22e-06	3.53e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	4.18e-06	3.5e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—coronary artery disease	4.18e-06	3.5e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	4.14e-06	3.47e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—coronary artery disease	4.1e-06	3.44e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK1—coronary artery disease	4.1e-06	3.43e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—coronary artery disease	4.08e-06	3.42e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	4.07e-06	3.41e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—coronary artery disease	4.04e-06	3.38e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—coronary artery disease	4.01e-06	3.36e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCND1—coronary artery disease	3.99e-06	3.35e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCND1—coronary artery disease	3.93e-06	3.29e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—coronary artery disease	3.88e-06	3.25e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	3.82e-06	3.2e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—coronary artery disease	3.81e-06	3.2e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—coronary artery disease	3.76e-06	3.15e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—coronary artery disease	3.7e-06	3.1e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	3.7e-06	3.1e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	3.55e-06	2.98e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—coronary artery disease	3.48e-06	2.92e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	3.43e-06	2.87e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—coronary artery disease	3.41e-06	2.86e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—coronary artery disease	3.38e-06	2.83e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—coronary artery disease	3.2e-06	2.68e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—coronary artery disease	3.15e-06	2.64e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	3.14e-06	2.63e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK1—coronary artery disease	3.13e-06	2.63e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—coronary artery disease	3.12e-06	2.61e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	3.08e-06	2.58e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—coronary artery disease	2.9e-06	2.43e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	2.72e-06	2.28e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	2.68e-06	2.24e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—coronary artery disease	2.41e-06	2.02e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—coronary artery disease	2.37e-06	1.99e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—coronary artery disease	2.22e-06	1.86e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—coronary artery disease	2.19e-06	1.83e-05	CbGpPWpGaD
